Rite Aid Corp. (RAD)
Management at Rite Aid Corporation (RAD - Analyst Report) was executing a turnaround strategy centered on increasing the profitability of the existing store base.
However, the acquisition of Brooks Eckerd prior to a convincing turnaround in profitability has increased the debt burden and interest expense.
Moreover, Wal-Mart's foray into the retail generic drug market has pressured the company's pharmacy margin. Given the weakness of front-end sales and management's continual lowering of EPS guidance (for larger net losses), the stock's rating remains Underperform.
|
|
|
Share |
RSS |
Rate Pos |
Rate Neg |
Comment |
|
|
||||||
Loading Stories...Most Popular on Zacks.com
More Zacks Resources
More Zacks Links
| Market Summary | Nov 25, 2009 06:49 am ET |

Sponsored Links 
0.00 %
-17.24
[CLICK TO CLOSE X]